Prostate-specific antigen concentrations in serum in acute illnesses

Clinical Chemistry

Volumn 42, Issue 11, 1996, Pages 1785-1788

  Honda, Stacey A A ^a,b   Goldstein, Alan P ^a,b   Morita, Thelma ^a   Sugiyama, Cheryl ^a   Cody, Linda ^a   Rios, Carlos N ^a,b   Bhagavan, Nadhipuram V ^a,b,c  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

acute phase reactants; macroglobulin; prostate carcinoma; tumor markers

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; OROSOMUCOID; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ACUTE PHASE RESPONSE; ADULT; AGED; AGING; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CARCINOMA; RADIOIMMUNOASSAY;

EID: 0029850051     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.11.1785     Document Type: Article

References (13)

1. Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application [Review]. Clin Chem 1993;39: 181-95.
2. Hara M, Koyanagi Y, Inoue T, Fukuyama T. Some physicochemical characteristics of gamma-seminoprotein; an antigenic component specific for human seminal plasma. Jpn J Legal Med 1971;25: 322-4.
3. Wang MC, Kuriyama M, Loor R, Li SC, Chu TM. Biochemical characterization of human prostatic antigen [Abstract]. Fed Proc 1981;40:1564.
4. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76: 1899-903.
5. McGee RS, Herr JC. Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30). Biol Reprod 1988;39:499-510.
6. Peehl DM. Prostate specific antigen role and function. Cancer 1995;75:2021-6.
7. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrin Metab 1992;75:1046-53.
8. Cohen P, Peehl DM, Graves HCB, Rosenfeld RG. Biological effects of prostate specific antigen (PSA) as an IGF binding protein-3 (IGFBP-3) protease. J Endocrinol 1994;142:407-15.
9. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate specific antigen and alpha-1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
10. Shott S. Statistics for health professionals. Philadelphia: WB Saunders Co., 1990:248-51.
11. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in community based population of healthy men: establishment of age-specific reference ranges. JAMA 1993;270:860-4.
12. Leinonen J, Zhang WM, Stenman UH. Complex formation between PSA isoenzymes and protease inhibitors. J Urol 1996;155:1099-103.
13. Christensson A, Laurell C, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine protease inhibitors. Eur J Biochem 1990;194:755-63.